Skip to main navigation

Site - Top Nav

  • Overview
  • Press & Events
    • Press Releases
    • Events
    • Media Kit
  • Stock
    • Stock Quote & Chart
    • Historic Price Lookup
  • Financials
    • SEC Filings
    • IRS Form 8937
  • Governance
    • Governance Documents
    • Committee Charters
    • Committee Composition
  • Resources
    • Investor Contact
    • Investor FAQs
    • Email Alerts
Precigen logo Precigen logo

Precigen

Advancing Medicine With Precision

Precigen logo
Precigen

Site - Top Nav

  • Overview
  • Press & Events
    • Press Releases
    • Events
    • Media Kit
  • Stock
    • Stock Quote & Chart
    • Historic Price Lookup
  • Financials
    • SEC Filings
    • IRS Form 8937
  • Governance
    • Governance Documents
    • Committee Charters
    • Committee Composition
  • Resources
    • Investor Contact
    • Investor FAQs
    • Email Alerts

Investors

Overview

Precigen: Advancing Medicine with PrecisionTM

Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.

Stock Quote

Data as of Feb 6, 2020 12:04 AM EST
Copyright West LLC. Minimum 15 minutes delayed.
Refresh quote

Site - Home - More Stock

  • View All
Press Releases
Feb 03, 2020
Precigen Completes Series Of Transactions To Solidify Healthcare Focus
Jan 09, 2020
Triple-Gene Announces Presentation at Upcoming Biotech Showcase Investor Conference
Jan 06, 2020
Precigen Receives FDA Orphan Drug Designation for PRGN-3006 UltraCAR-T™ in Patients with Acute Myeloid Leukemia (AML)

Site - Home - More News

  • View All News
Events
Jan 14, 2020 from 5:00 PM to 5:25 PM PST
38th Annual J.P. Morgan Healthcare Conference
Listen to webcast
Dec 8, 2019 at 6:00 PM EST
61st ASH Annual Meeting & Exposition
Dec 5, 2019 at 12:10 PM PST
World Vaccine & Immunotherapy Congress

Site - Home - More Events

  • View All Events

Site - Footer Nav

Press & Events
  • Press Releases
  • Events
  • Media Kit
Stock
  • Stock Quote & Chart
  • Historic Price Lookup
Financials
  • SEC Filings
  • IRS Form 8937
Governance
  • Governance Documents
  • Committee Charters
  • Committee Composition
Resources
  • Investor Contact
  • Investor FAQs
  • Email Alerts
Contact
  • investors@precigen.com
Location
  • Precigen, Inc.
    20358 Seneca Meadows Parkway
    Germantown, MD
    20876
Connect with us

© Copyright PRECIGEN: Advancing Medicine With Precision. All rights reserved. Privacy Policy | Legal Notices

Cookie Policy

This website uses analytical and tracking cookies to improve your user experience and for statistical purposes. By continuing to browse on this website, you agree to the use of such cookies.

Click here to learn more about cookies and how you can manage them.

Manage Cookies

Strictly Necessary

Cookies needed for the website to work correctly.

Important functions

Cookies that are needed for the website to work optimally and to remember who you are.

Optional

Cookies that allow us to record statistics that can improve our service and that provide you relevant information.

Cookies have been blocked and this website is no longer accessible. To manage your cookie configuration, click one of the buttons below.